Formation Bio
Wenjun (Wendy) Ma is an accomplished statistical programming professional with extensive experience in the pharmaceutical industry. Currently serving as the Sr. Director and Head of Statistical Programming at TrialSpark since January 2023, Ma previously held positions at Sumitomo Pharma Oncology as Director of Statistical Programming, and at Bristol Myers Squibb as Associate Director. Prior roles include Sr. Manager of Statistical Programming at Celgene and Manager of Biostatistics Programming at Amgen, where Ma worked from 2006 to 2018. Beginning the career as a Sr. Statistician at HealthEast Care System, Ma's educational background includes a Master of Science in Biostatistics from the University of Minnesota and a Doctor of Medicine from Tongji Medical University.
This person is not in any teams
This person is not in any offices
Formation Bio
5 followers
Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.